Post-earnings recap
Reported
Tue, Feb 24, 2026
EPS actual
$-5.63
EPS est.
$-1.46
EPS surprise
-284.83%
1-day move
+1.81%
Vaxcyte's earnings report shows a significant loss per share, which is concerning for investors. However, the stock reacted positively, rising 1.81%, possibly due to market expectations or other external factors. The lack of revenue data and guidance leaves uncertainty about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-5.63 | N/A | -284.83% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about the current operational landscape. They highlighted ongoing challenges but did not provide specific guidance for the future.
Management acknowledged the challenges faced during the quarter.
They emphasized ongoing efforts to address operational hurdles.
Future strategies were discussed but lacked specific timelines.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—